Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

Losartan affects the substrate for atrial fibrillation maintenance in a rabbit model.

Zhao Y, Gu TX, Zhang GW, Liu HG, Wang C.

Cardiovasc Pathol. 2013 Sep-Oct;22(5):383-8. doi: 10.1016/j.carpath.2013.02.005. Epub 2013 Mar 23.

PMID:
23528876
2.

Atrial fibrillation induces myocardial fibrosis through angiotensin II type 1 receptor-specific Arkadia-mediated downregulation of Smad7.

He X, Gao X, Peng L, Wang S, Zhu Y, Ma H, Lin J, Duan DD.

Circ Res. 2011 Jan 21;108(2):164-75. doi: 10.1161/CIRCRESAHA.110.234369. Epub 2010 Dec 2.

3.

Effects of Cilazapril on atrial electrical, structural and functional remodeling in atrial fibrillation dogs.

Li Y, Li W, Yang B, Han W, Dong D, Xue J, Li B, Yang S, Sheng L.

J Electrocardiol. 2007 Jan;40(1):100.e1-6. Epub 2006 Oct 25.

PMID:
17067622
4.

Mechanisms with clinical implications for atrial fibrillation-associated remodeling: cathepsin K expression, regulation, and therapeutic target and biomarker.

Fujita M, Cheng XW, Inden Y, Shimano M, Yoshida N, Inoue A, Yamamoto T, Takeshita K, Kyo S, Taguchi N, Shi GP, Kuzuya M, Okumura K, Murohara T.

J Am Heart Assoc. 2013 Dec 16;2(6):e000503. doi: 10.1161/JAHA.113.000503.

5.
6.

Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort.

Li D, Fareh S, Leung TK, Nattel S.

Circulation. 1999 Jul 6;100(1):87-95.

7.

Pirfenidone prevents the development of a vulnerable substrate for atrial fibrillation in a canine model of heart failure.

Lee KW, Everett TH 4th, Rahmutula D, Guerra JM, Wilson E, Ding C, Olgin JE.

Circulation. 2006 Oct 17;114(16):1703-12. Epub 2006 Oct 9.

8.

The effects of cilazapril and valsartan on the mRNA and protein expressions of atrial calpains and atrial structural remodeling in atrial fibrillation dogs.

Li Y, Li WM, Gong YT, Li BX, Liu W, Han W, Dong D, Sheng L, Xue JY, Zhang L, Chu S, Yang BF.

Basic Res Cardiol. 2007 May;102(3):245-56. Epub 2007 Feb 2.

PMID:
17268887
9.

Effects of Losartan on acute atrial electrical remodeling.

Li Y, Li WM, Xue JY, Han W, Yang SS, Gu HY.

Chin Med J (Engl). 2004 May;117(5):643-6.

PMID:
15161526
10.

Effects of irbesartan on gene expression revealed by transcriptome analysis of left atrial tissue in a porcine model of acute rapid pacing in vivo.

Chilukoti RK, Mostertz J, Bukowska A, Aderkast C, Felix SB, Busch M, Völker U, Goette A, Wolke C, Homuth G, Lendeckel U.

Int J Cardiol. 2013 Oct 3;168(3):2100-8. doi: 10.1016/j.ijcard.2013.01.007. Epub 2013 Feb 12.

PMID:
23414741
11.

Angiotensin II type 1 receptor inhibition is associated with reduced tachyarrhythmia-induced ventricular interstitial fibrosis in a goat atrial fibrillation model.

Chrysostomakis SI, Karalis IK, Simantirakis EN, Koutsopoulos AV, Mavrakis HE, Chlouverakis GI, Vardas PE.

Cardiovasc Drugs Ther. 2007 Oct;21(5):357-65.

PMID:
17909956
12.

High resolution mapping of the pulmonary vein and the vein of Marshall during induced atrial fibrillation and atrial tachycardia in a canine model of pacing-induced congestive heart failure.

Okuyama Y, Miyauchi Y, Park AM, Hamabe A, Zhou S, Hayashi H, Miyauchi M, Omichi C, Pak HN, Brodsky LA, Mandel WJ, Fishbein MC, Karagueuzian HS, Chen PS.

J Am Coll Cardiol. 2003 Jul 16;42(2):348-60.

13.

Enalapril prevents perpetuation of atrial fibrillation by suppressing atrial fibrosis and over-expression of connexin43 in a canine model of atrial pacing-induced left ventricular dysfunction.

Sakabe M, Fujiki A, Nishida K, Sugao M, Nagasawa H, Tsuneda T, Mizumaki K, Inoue H.

J Cardiovasc Pharmacol. 2004 Jun;43(6):851-9.

PMID:
15167279
14.
15.

Rosiglitazone attenuates atrial structural remodeling and atrial fibrillation promotion in alloxan-induced diabetic rabbits.

Liu T, Zhao H, Li J, Korantzopoulos P, Li G.

Cardiovasc Ther. 2014 Aug;32(4):178-83. doi: 10.1111/1755-5922.12079.

PMID:
24814361
16.

Probucol attenuates atrial autonomic remodeling in a canine model of atrial fibrillation produced by prolonged atrial pacing.

Gong YT, Li WM, Li Y, Yang SS, Sheng L, Yang N, Shan HB, Xue HJ, Liu W, Yang BF, Dong DL, Li BX.

Chin Med J (Engl). 2009 Jan 5;122(1):74-82.

PMID:
19187621
17.

Downregulation of angiotensin converting enzyme II is associated with pacing-induced sustained atrial fibrillation.

Pan CH, Lin JL, Lai LP, Chen CL, Stephen Huang SK, Lin CS.

FEBS Lett. 2007 Feb 6;581(3):526-34. Epub 2007 Jan 17.

18.
19.

Pioglitazone, a peroxisome proliferator-activated receptor-gamma activator, attenuates atrial fibrosis and atrial fibrillation promotion in rabbits with congestive heart failure.

Shimano M, Tsuji Y, Inden Y, Kitamura K, Uchikawa T, Harata S, Nattel S, Murohara T.

Heart Rhythm. 2008 Mar;5(3):451-9. doi: 10.1016/j.hrthm.2007.12.010. Epub 2007 Dec 23.

PMID:
18313605
20.

d,l-Sotalol reverses abbreviated atrial refractoriness and prevents promotion of atrial fibrillation in a canine model with left ventricular dysfunction induced by atrial tachypacing.

Sakamoto T, Fujiki A, Nakatani Y, Sakabe M, Mizumaki K, Hashimoto N, Inoue H.

Circ J. 2009 Oct;73(10):1820-8. Epub 2009 Aug 27.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk